Evaluation of a Plasma Marker (p-Tau217) for the Biological Diagnosis of Alzheimer's Disease, and Comparison With CSF Markers

NCT07071649 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer's Disease
Biomarkers
Non-invasive Diagnosis
Phosphorylated Protein p-tau217

Interventions

OTHER: blood withdrawal

Sponsor

Centre Hospitalier Universitaire, Amiens